Minocycline, a microglial inhibitor, reduces ‘honey trap’ risk in huma

  • Thread starter Kholdstare
  • Start date
In summary, minocycline, a tetracycline antibiotic, has been reported to improve symptoms of psychiatric disorders and to facilitate sober decision-making in healthy human subjects. Here we show that minocycline also reduces the risk of the ‘honey trap’ during an economic exchange. Males tend to cooperate with physically attractive females without careful evaluation of their trustworthiness, resulting in betrayal by the female. In this experiment, healthy male participants made risky choices (whether or not to trust female partners, identified only by photograph, who had decided in advance to exploit the male participants). The results show that trusting behaviour in male participants significantly increased in relation to the perceived attractiveness of the female partner, but that attractiveness did not
  • #1
Kholdstare
388
1
Recently, minocycline, a tetracycline antibiotic, has been reported to improve symptoms of psychiatric disorders and to facilitate sober decision-making in healthy human subjects. Here we show that minocycline also reduces the risk of the ‘honey trap’ during an economic exchange. Males tend to cooperate with physically attractive females without careful evaluation of their trustworthiness, resulting in betrayal by the female. In this experiment, healthy male participants made risky choices (whether or not to trust female partners, identified only by photograph, who had decided in advance to exploit the male participants). The results show that trusting behaviour in male participants significantly increased in relation to the perceived attractiveness of the female partner, but that attractiveness did not impact trusting behaviour in the minocycline group. Animal studies have shown that minocycline inhibits microglial activities. Therefore, this minocycline effect may shed new light on the unknown roles microglia play in human mental activities.

http://www.nature.com/srep/2013/130418/srep01685/full/srep01685.html
 
Biology news on Phys.org
  • #2
WOW very interesting post. Luckily I think I am too old to be affected by a pretty face anymore.

Here is a link from Pub-Med that is probably the source of your link.

http://www.ncbi.nlm.nih.gov/pubmed/23595250

The words nature or natural in the name of a website will sometimes get a post deleted except in general discussion.

Quite evidently the studies were done in Japan. (nothing wrong with that):approve:

here is one that really goes in depth. (It might be a long version of the same one study).

http://www.plosone.org/article/info:doi/10.1371/journal.pone.0040461
 
Last edited:
  • #3
The words nature or natural in the name of a website will sometimes get a post deleted except in general discussion.

WHAT? Its from Nature Publishing Group. Have people started to become dumb?
 
  • #4
Nature, of course, published the original papers by Watson, Crick and Wilkins on the double helix structure of DNA in 1953. As far as I know, it remains a leading journal in the life sciences. Unfortunately, Rosalind Franklin was not given sufficient credit at the time for her contributions

http://www.nature.com/nature/dna50/archive.html
 
  • #5
edward said:
WOW very interesting post. Luckily I think I am too old to be affected by a pretty face anymore.

Here is a link from Pub-Med that is probably the source of your link.

http://www.ncbi.nlm.nih.gov/pubmed/23595250

The words nature or natural in the name of a website will sometimes get a post deleted except in general discussion.

Quite evidently the studies were done in Japan. (nothing wrong with that):approve:

here is one that really goes in depth. (It might be a long version of the same one study).

http://www.plosone.org/article/info:doi/10.1371/journal.pone.0040461

He posted the study, from the journal nature no doubt too :)
 

1. What is minocycline and how does it work as a microglial inhibitor?

Minocycline is an antibiotic commonly used to treat bacterial infections. It works as a microglial inhibitor by suppressing the activation and function of microglial cells, which are immune cells found in the brain and spinal cord.

2. What is the significance of reducing 'honey trap' risk in humans?

'Honey trap' refers to a type of online scam where individuals are tricked into revealing personal information to malicious actors. By reducing the risk of falling for these scams, minocycline can help protect individuals from identity theft and other forms of cybercrime.

3. How does minocycline reduce 'honey trap' risk in humans?

Studies have shown that microglial cells play a role in our decision-making processes and can be influenced by external stimuli, such as online scams. By inhibiting the function of these cells, minocycline can help reduce impulsive decision-making and decrease susceptibility to falling for 'honey trap' scams.

4. Are there any potential side effects of taking minocycline as a microglial inhibitor?

As with any medication, there are potential side effects of taking minocycline. Common side effects include nausea, vomiting, diarrhea, and dizziness. In rare cases, more serious side effects such as allergic reactions and liver damage may occur.

5. Is minocycline FDA-approved for use as a microglial inhibitor to reduce 'honey trap' risk in humans?

No, minocycline is not currently FDA-approved for this specific use. While it is an FDA-approved medication for treating bacterial infections, its use as a microglial inhibitor for reducing 'honey trap' risk is still being studied and has not yet been formally approved.

Hot Threads

Recent Insights

Back
Top